Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Polley

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Molecular Cancer Therapeutics|September 10, 2015
Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA ExpressionBeverly A Teicher, Eric Polley, Mark Kunkel, et al.
Cancer Research|April 28, 2017
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic ActivitySusan L Holbeck, Richard Camalier, James A Crowell, et al.
American Heart Journal|March 9, 2023
Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning methodChe Ngufor, Xiaoxi Yao, Jonathan W Inselman, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|July 17, 2024
Outcomes and Attributes Patients Value When Choosing Glucose-Lowering Medications: A Mixed-Methods StudyElizabeth H Golembiewski, Andrea E Garcia Bautista, Eric Polley, et al.
Journal of the National Cancer Institute|June 2, 2016
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA ExpressionEric Polley, Mark Kunkel, David Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017
Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)Shivaani Kummar, Geraldine O'Sullivan Coyne, Khanh T Do, et al.
Frontiers in Oncology|June 3, 2025
Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft modelsYvonne A Evrard, Sergio Y Alcoser, Michael Mullendore, et al.
JCO Precision Oncology|April 30, 2021
Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II TrialAlice P Chen, Shivaani Kummar, Nancy Moore, et al.
Nature Biotechnology|October 27, 2015
Comprehensive characterization of the Published Kinase Inhibitor SetJonathan M Elkins, Vita Fedele, Marta Szklarz, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Molecular Cancer Therapeutics|September 10, 2015
Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA ExpressionBeverly A Teicher, Eric Polley, Mark Kunkel, et al.
Cancer Research|April 28, 2017
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic ActivitySusan L Holbeck, Richard Camalier, James A Crowell, et al.
American Heart Journal|March 9, 2023
Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning methodChe Ngufor, Xiaoxi Yao, Jonathan W Inselman, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|July 17, 2024
Outcomes and Attributes Patients Value When Choosing Glucose-Lowering Medications: A Mixed-Methods StudyElizabeth H Golembiewski, Andrea E Garcia Bautista, Eric Polley, et al.
Journal of the National Cancer Institute|June 2, 2016
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA ExpressionEric Polley, Mark Kunkel, David Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017
Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)Shivaani Kummar, Geraldine O'Sullivan Coyne, Khanh T Do, et al.
Frontiers in Oncology|June 3, 2025
Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft modelsYvonne A Evrard, Sergio Y Alcoser, Michael Mullendore, et al.
JCO Precision Oncology|April 30, 2021
Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II TrialAlice P Chen, Shivaani Kummar, Nancy Moore, et al.
Nature Biotechnology|October 27, 2015
Comprehensive characterization of the Published Kinase Inhibitor SetJonathan M Elkins, Vita Fedele, Marta Szklarz, et al.
Pageof 3